Why Amazon stock stumbled today

Investors sell out of the company, albeit modestly, after a rival's bid is selected for a choice asset.

| More on:
A businessman slips and spills his coffee.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

This article was originally published on Fool.com. All figures quoted in US dollars unless otherwise stated.

What happened

Monster retailer Amazon (NASDAQ: AMZN) doesn't often lose, so shareholders get discouraged when the company doesn't come in first in a contest. That was the situation on Tuesday, when a rival's bid was selected for a big healthcare asset that was in play. As a result, Amazon's share price closed the day over 1% lower, a steeper fall than that of the S&P 500 index.

So what

Amazon was vying for healthcare services company Signify Health, but the nod ended up going to CVS Health, whose bid was worth roughly $8 billion. Other companies participating in the effort to acquire Signify were UnitedHealth Group and Option Care Health.

Among that crowd, Amazon was a bit of an outlier. UnitedHealth and Option Care are pure-play healthcare companies. Amazon, which has always aimed to be a retailer of any product or service imaginable, is still considered by many to be more of a giant online shopping outlet than a provider of healthcare services.

In Signify's press release announcing its selection of CVS, CEO Kyle Armbrester said that "we determined that CVS Health is the ideal partner, given its focus on expanding access to health services and helping consumers navigate to the best sites of care."

While Amazon has indisputably made strides in its medical business efforts -- witness its $3.9 billion deal for primary care provider 1Life Healthcare earlier this year -- it still isn't readily identified with that sector. It wouldn't be surprising if this made the company a dark horse candidate, at best, in the Signify bidding.

Now what

Amazon isn't known for setbacks and management probably isn't too fond of them, so we can expect the company to make fresh bids for other healthcare businesses that come into play. But other entities with deep pockets will also be looking to buy, so Signify might not be the last of its defeats in the sector.

This article was originally published on Fool.com. All figures quoted in US dollars unless otherwise stated.

John Mackey, CEO of Whole Foods Market, an Amazon subsidiary, is a member of The Motley Fool’s board of directors. Eric Volkman has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Amazon. The Motley Fool Australia has recommended Amazon. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on International Stock News

A tech worker wearing a mask holds a computer chip.
International Stock News

Will Nvidia crush the market again in 2026?

The chipmaker has an excellent track record.

Read more »

A man with a wide, eager smile on his face holds up three fingers.
International Stock News

The 3 smartest quantum computing stocks to buy with $1,000 in 2026

While pure plays like IonQ and Rigetti Computing get most of the attention, investors can gain exposure to quantum computing…

Read more »

A woman sits at her computer with her chin resting on her hand as she contemplates her next potential investment.
International Stock News

Alphabet just did something it hasn't done in 7 years. Time to buy?

Alphabet is a key player in the high-growth AI market.

Read more »

Investor kissing piggy bank.
International Stock News

Ranking the best "Magnificent Seven" stocks to buy for 2026. Here's my No. 1 pick.

In today's premium-priced stock market, investors can turn to Microsoft for growth at a compelling value.

Read more »

A young woman sits with her hand to her chin staring off to the side thinking about her investments.
International Stock News

Should you invest $1,000 in Nvidia right now?

It has gained more than 1,000% over the past five years.

Read more »

Man charging an electric vehicle.
International Stock News

Should you buy Tesla while it's below $500?

The "Magnificent Seven" stock currently trades 5% below its record high from a year ago.

Read more »

A woman sits at her computer with her chin resting on her hand as she contemplates her next potential investment.
International Stock News

Is Gemini Enterprise a game changer for Alphabet?

Gemini Enterprise is Alphabet's answer to its future in enterprise AI.

Read more »

A man looking at his laptop and thinking.
International Stock News

Nvidia stock price slumped 12.6% in November. What's next for the artificial intelligence (AI) behemoth?

Nvidia posted another blowout quarter in November. Its stock still fell. Why?

Read more »